(Q37159565)

18 August 2017

1 reference

title

Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy (English)

1 reference

invasive fungal infections

18 August 2017

main subject

1 reference

H Hof

1

1 reference

18 August 2017

language of work or name

1 reference

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

51 Suppl 1

1 reference

18 August 2017

page(s)

1-6

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Update on antifungal treatment of invasive Candida and Aspergillus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Changing patterns and trends in systemic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Invasive Candida species infections: a 5 year population-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Active surveillance for candidemia, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Developments in the treatment of candidiasis: more choices and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Attributable mortality of nosocomial candidemia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Virulence in Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Fungal infections in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Molecular aspects of fluconazole resistance development in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Antibiotic resistance surveillance: action for international studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Mucormycosis: an emerging disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01522.X

10.1111/J.1439-0507.2008.01522.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference